AI leaders urge Congress to regulate synthetic DNA sales to prevent bioweapon development. Major industry figures are calling for stricter oversight of companies providing genetic material, aiming to close a critical biosecurity gap and mitigate pandemic risks. This coordinated effort highlights growing concerns about the misuse of advanced AI technologies.
Opening Kapyn…